サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1429330

創薬における人工知能（AI）の世界市場レポート 2024

Artificial Intelligence (AI) In Drug Discovery Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
創薬における人工知能（AI）の世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

創薬における人工知能（AI）の市場規模は、今後数年間で急激に成長すると予想されています。 2028年には27.4%の年間複合成長率（CAGR）で47億1,000万米ドルに成長すると予想されます。創薬用 AIの成長が期待されるのは、政府の支援、ヘルスケア費の増大、クラウドベースのアプリケーションの採用増加によって促進されます。動向には、マルチオミクスデータの統合、標的選択と薬剤スクリーニングにおけるAI、AIイノベーションラボの設立、投資の強化、業界のパートナーシップと協力が含まれます。

個別化医療に対する需要の高まりが、創薬における人工知能（AI）市場の急成長の原動力となっています。個人の遺伝子やタンパク質の知識に基づいて治療を調整する個別化医療の重要性が高まっています。 AIの極めて重要な役割は、臨床開発のさまざまな段階と、新しいパーソナライズされた健康ソリューションの作成に及びます。これは、適切な介入ターゲットを特定し、その有効性を評価するのに非常に役立ちます。注目すべきことに、米国FDAが2022年に新たに承認された治療用分子実体の約34％に相当する12の個別化医薬品を承認したことが、この急増を証明しています。個別化医療に対する需要の高まりにより、創薬における人工知能（AI）市場の拡大が促進されています。

創薬における人工知能（AI）市場の成長を促進する実質的な触媒は、創薬プロセスを合理化する需要の高まりです。従来、動物モデルによる分子の同定と最適化には、人間による評価までに通常3～5年かかります。しかし、AIベースの新興企業は、数日から数か月以内に新薬を特定して設計できる能力を示しています。実例としては、AlphaFoldタンパク質構造データベースが2021年 12月に拡張されました。Google DeepMindがEMBLの欧州バイオインフォマティクス研究所（EMBL-EBI）と協力して開発したこのデータベースには、Swiss-Protから注意深く精選された440,000個のタンパク質構造が追加されました。この大幅な拡張により、データベースのサイズは2倍以上の800,000構造を超え、創薬プロセスが著しく加速されました。創薬手続き全体の期間のこの大幅な短縮は、創薬における人工知能（AI）市場の成長を支える重要な推進力です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 創薬市場における世界の人工知能（AI）、技術別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • ディープラーニング
  • 機械学習
  • 創薬市場における世界の人工知能（AI）、薬剤タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 低分子
  • 高分子
  • 創薬市場における世界の人工知能（AI）、治療タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 代謝性疾患
  • 循環器疾患
  • 腫瘍学
  • 神経変性疾患
  • その他の治療
  • 創薬市場における世界の人工知能（AI）、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 製薬会社
  • バイオ医薬品企業
  • 学術研究機関
  • その他のエンドユーザー

第7章 地域および国の分析

  • 創薬市場における世界の人工知能（AI）、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 創薬市場における世界の人工知能（AI）、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 創薬市場の競合情勢における人工知能（AI）
  • 創薬市場における人工知能（AI）企業プロファイル
    • IBM Corporation
    • Microsoft Corporation
    • NVIDIA Corporation
    • Exscientia
    • Alphabet

第31章 その他の大手および革新的な企業

  • Atomwise Inc.
  • Insilico Medicine
  • Owkin Inc
  • Xtalpi Inc
  • Cloud Pharmaceuticals
  • Shanghai Pharmaceutics
  • Standigm
  • Indegene
  • Intuition Systems
  • Innoplexus
  • Takeda Pharmaceutical Company Ltd.
  • RxPrism
  • Otsuka Pharmaceutical Co. Ltd.
  • China National Pharmaceutical Group Co., Ltd.
  • Jiangsu Hengrui Medicine Co., Ltd

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r14342

Artificial intelligence (AI) is a technology that simulates human intelligence in machines, enabling them to think and behave such as humans. AI is known for its ability to perform tasks quickly and with relatively few errors.

The primary technologies employed in AI for drug discovery are deep learning and machine learning. Deep learning is a technique within machine learning and AI that emulates how humans acquire knowledge. Data science, encompassing statistics and predictive modeling, integrates deep learning as a crucial component. Drug discovery involves various types of drugs, including small molecules and large molecules, and encompasses different therapeutic approaches such as c and others. The implementation of AI in drug discovery is seen across various end-users, including pharmaceutical companies, biopharmaceutical companies, academic and research institutes, among others.

The artificial intelligence (AI) in drug discovery market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI) in drug discovery market statistics, including artificial intelligence (AI) in drug discovery industry global market size, regional shares, competitors with a artificial intelligence (AI) in drug discovery market share, detailed artificial intelligence (AI) in drug discovery market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI) in drug discovery industry. This artificial intelligence (AI) in drug discovery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial intelligence (ai) in drug discovery market size has grown exponentially in recent years. It will grow from $1.37 billion in 2023 to $1.79 billion in 2024 at a compound annual growth rate (CAGR) of 30.8%. The growth observed in the historic period in the field of artificial intelligence (AI) in drug discovery can be attributed to several key factors. These include the growth in emerging markets, the rising prevalence of chronic diseases, the increased adoption of artificial intelligence for cost-efficient drug discovery, and the implementation of increasingly strict quality regulations for drug manufacturers.

The artificial intelligence (ai) in drug discovery market size is expected to see exponential growth in the next few years. It will grow to $4.71 billion in 2028 at a compound annual growth rate (CAGR) of 27.4%. Anticipated growth in AI for drug discovery is driven by government support, growing healthcare expenditure, and increased adoption of cloud-based applications. Trends include the integration of multi-omics data, AI in target selection and drug screening, establishment of AI innovation labs, heightened investments, and industry partnerships and collaborations.

The escalating demand for personalized medicine stands as a driving force behind the burgeoning growth of the artificial intelligence (AI) in drug discovery market. Personalized medicine, which tailors treatments based on individual genetic or protein knowledge, has surged in importance. AI's pivotal role spans various phases of clinical development and in the creation of new personalized health solutions. It significantly aids in identifying suitable intervention targets and evaluating their effectiveness. Notably, the US FDA's approval of 12 personalized medicines in 2022, representing about 34% of newly endorsed therapeutic molecular entities, attests to this surge. The heightened demand for personalized medicine is thereby fueling the expansion of the AI in drug discovery market.

A substantial catalyst propelling the artificial intelligence (AI) in drug discovery market growth is the mounting demand to streamline the drug discovery process. Conventionally, the identification and optimization of molecules through animal models typically span three to five years before human evaluation. However, AI-based startups have shown the ability to identify and design new drugs within days or months. An illustrative example is the AlphaFold Protein Structure Database's expansion in December 2021. Developed by Google DeepMind in collaboration with EMBL's European Bioinformatics Institute (EMBL-EBI), this database added 440k meticulously curated protein structures from Swiss-Prot. This significant expansion more than doubled the database's size to over 800k structures, accelerating the drug discovery process remarkably. This substantial reduction in the overall duration of drug discovery procedures is a key driver underpinning the growth of the AI in drug discovery market.

Major players in the AI drug delivery sector are forging strategic collaborations to delve deeper into drug discovery leveraging AI, a move that's elevating their position within the artificial intelligence in drug discovery market. Take Atomwise, a US-based AI systems company, which partnered with Sanofi in August 2022. This collaboration aims to identify and explore up to five pharmacological targets utilizing Atomwise's AI-driven AtomNet technology. To facilitate the discovery of lead compounds for Sanofi's exclusive targets, Atomwise received an initial payment of $20 million from Sanofi, a prominent French pharmaceutical and healthcare company.

Major corporations are making significant investments in entities operating within the artificial intelligence (AI) in drug discovery domain. These investments aim to facilitate the identification and design of novel therapies, ultimately offering these models to other pharmaceutical firms. Given that drug discovery is both capital-intensive and time-consuming, such strategic investments provide vital funding for research and development of new drugs. This funding often serves as a catalyst for these companies to propel their drug discovery initiatives, expediting the introduction of new treatments into the market. For instance, in July 2023, Nvidia, a leading US-based software company, made a $50 million investment in Recursion Pharmaceuticals, a US-based biotech firm harnessing artificial intelligence (AI) for drug discovery. This infusion of capital is poised to empower Recursion in accelerating the development of its AI foundation models for biology and chemistry by leveraging Nvidia's cloud services.

In December 2022, Tecnotree Corporation, a Finnish telecommunications company, successfully acquired CognitiveScale for a total investment of $6 million. This strategic acquisition is expected to significantly boost Tecnotree's AI capabilities, presenting potential opportunities for the pharmaceutical industry. Leveraging these enhanced AI capabilities, Tecnotree aims to explore and develop innovative AI-powered solutions for drug discovery and advancement. CognitiveScale, a reputable AI software company based in the United States, will contribute to Tecnotree's strategic vision in this evolving landscape.

Major companies operating in the artificial intelligence (ai) in drug discovery market report are IBM Corporation, Microsoft Corporation, NVIDIA Corporation, Exscientia, Alphabet, Atomwise Inc., Insilico Medicine, Owkin Inc., Xtalpi Inc., Cloud Pharmaceuticals, Shanghai Pharmaceuticals, Standigm, Indegene, Intuition Systems, Innoplexus, Takeda Pharmaceutical Company Ltd., RxPrism, Otsuka Pharmaceutical Co. Ltd., China National Pharmaceutical Group Co., Ltd., Jiangsu Hengrui Medicine Co., Ltd., Cipla Limited, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Sun Pharma, Tricog Health Services Pvt. Ltd., Alliance Pharm Pte Ltd., GSK Australia , CytoReason, IIPharma, StoneWise, Adagene, GT Apeiron Therapeutics, Xbiome, Accutar Biotech, DeepMind, Renalytix AI, Iktos, Ipsen Pharma, Galderma S.A., BenevolentAI, Deepflare, Novartis, Gero, Ardigen, Botkin, Care Mentor AI , Diagnocat, GNS Healthcare, Merck & Co., Apotex, Pfizer, Gilead Sciences, Roche, Bayer, AbbVie Inc., GlaxoSmithKline, AstraZeneca, Amgen, Sanofi Pasteur, Abbott Laboratories, Janssen Pharmaceutica, Teva Canada, Accord Healthcare Inc., Acerus Pharmaceuticals Corporation, AA Pharma Inc., Sanfer, Siegfried Rhein, Atomwise, Inc., Bioage, NuMedii, Envisagenics, Aria Pharmaceuticals, Verge Genomics, Berg LLC, Deep Genomics, Cyclica , IQVIA, Quris, GE Healthcare, Avanade , Group42 Holding Ltd., Ilara Health, Adcock Ingram , Johnson & Johnson, Eurolab , Ranbaxy (SA) (Pty) Ltd., Aspen, Rology, hearX Group, DilenyTech

North America was the largest region in the artificial intelligence (AI) in drug discovery market in 2023. Western Europe was the second largest region in the global artificial intelligence (AI) in drug discovery market share. The regions covered in the artificial intelligence (ai) in drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the artificial intelligence (ai) in drug discovery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The artificial intelligence (AI) in drug discovery market includes revenues earned by entities by offering AI for drug discovery. Artificial Intelligence (AI) for drug discovery is a technology that uses a simulation of the human intelligence process by machines to tackle complex problems in the drug discovery process. It helps to find new molecules to identify drug targets and develop personalized medicines in the pharmaceutical industry. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence (AI) In Drug Discovery Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial intelligence (ai) in drug discovery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence (ai) in drug discovery? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The artificial intelligence (ai) in drug discovery market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Technology: Context-Aware Processing; Natural Language Processing; Querying Method; Deep Learning
  • 2) By Drug Type: Small Molecules; Large Molecules
  • 3) By Therapeutic Type: Metabolic Disease; Cardiovascular Disease; Oncology; Neurodegenerative Diseases; Anti-Infective Diseases; Respiratory Diseases; Other Therapeutics
  • 4) By End User: Pharmaceutical Companies; Biopharmaceutical Companies; Academic And Research Institutes; Other End-Users
  • Companies Mentioned: IBM Corporation; Microsoft Corporation; NVIDIA Corporation; Exscientia; Alphabet
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Intelligence (AI) In Drug Discovery Market Characteristics

3. Artificial Intelligence (AI) In Drug Discovery Market Trends And Strategies

4. Artificial Intelligence (AI) In Drug Discovery Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Artificial Intelligence (AI) In Drug Discovery Market Size and Growth

  • 5.1. Global Artificial Intelligence (AI) In Drug Discovery Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Artificial Intelligence (AI) In Drug Discovery Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Artificial Intelligence (AI) In Drug Discovery Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Artificial Intelligence (AI) In Drug Discovery Market Segmentation

  • 6.1. Global Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Deep Learning
  • Machine Learning
  • 6.2. Global Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Small Molecule
  • Large Molecules
  • 6.3. Global Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Metabolic Disease
  • Cardiovascular Disease
  • Oncology
  • Neurodegenerative Diseases
  • Other Therapeutics
  • 6.4. Global Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pharmaceutical Companies
  • Biopharmaceutical Companies
  • Academic And Research Institutes
  • Other End-Users

7. Artificial Intelligence (AI) In Drug Discovery Market Regional And Country Analysis

  • 7.1. Global Artificial Intelligence (AI) In Drug Discovery Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Artificial Intelligence (AI) In Drug Discovery Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Artificial Intelligence (AI) In Drug Discovery Market

  • 8.1. Asia-Pacific Artificial Intelligence (AI) In Drug Discovery Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Artificial Intelligence (AI) In Drug Discovery Market

  • 9.1. China Artificial Intelligence (AI) In Drug Discovery Market Overview
  • 9.2. China Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Artificial Intelligence (AI) In Drug Discovery Market

  • 10.1. India Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Artificial Intelligence (AI) In Drug Discovery Market

  • 11.1. Japan Artificial Intelligence (AI) In Drug Discovery Market Overview
  • 11.2. Japan Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Artificial Intelligence (AI) In Drug Discovery Market

  • 12.1. Australia Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Artificial Intelligence (AI) In Drug Discovery Market

  • 13.1. Indonesia Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Artificial Intelligence (AI) In Drug Discovery Market

  • 14.1. South Korea Artificial Intelligence (AI) In Drug Discovery Market Overview
  • 14.2. South Korea Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Artificial Intelligence (AI) In Drug Discovery Market

  • 15.1. Western Europe Artificial Intelligence (AI) In Drug Discovery Market Overview
  • 15.2. Western Europe Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Artificial Intelligence (AI) In Drug Discovery Market

  • 16.1. UK Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Artificial Intelligence (AI) In Drug Discovery Market

  • 17.1. Germany Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Artificial Intelligence (AI) In Drug Discovery Market

  • 18.1. France Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Artificial Intelligence (AI) In Drug Discovery Market

  • 19.1. Italy Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Artificial Intelligence (AI) In Drug Discovery Market

  • 20.1. Spain Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Artificial Intelligence (AI) In Drug Discovery Market

  • 21.1. Eastern Europe Artificial Intelligence (AI) In Drug Discovery Market Overview
  • 21.2. Eastern Europe Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Artificial Intelligence (AI) In Drug Discovery Market

  • 22.1. Russia Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Artificial Intelligence (AI) In Drug Discovery Market

  • 23.1. North America Artificial Intelligence (AI) In Drug Discovery Market Overview
  • 23.2. North America Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Artificial Intelligence (AI) In Drug Discovery Market

  • 24.1. USA Artificial Intelligence (AI) In Drug Discovery Market Overview
  • 24.2. USA Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Artificial Intelligence (AI) In Drug Discovery Market

  • 25.1. Canada Artificial Intelligence (AI) In Drug Discovery Market Overview
  • 25.2. Canada Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Artificial Intelligence (AI) In Drug Discovery Market

  • 26.1. South America Artificial Intelligence (AI) In Drug Discovery Market Overview
  • 26.2. South America Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Artificial Intelligence (AI) In Drug Discovery Market

  • 27.1. Brazil Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Artificial Intelligence (AI) In Drug Discovery Market

  • 28.1. Middle East Artificial Intelligence (AI) In Drug Discovery Market Overview
  • 28.2. Middle East Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Artificial Intelligence (AI) In Drug Discovery Market

  • 29.1. Africa Artificial Intelligence (AI) In Drug Discovery Market Overview
  • 29.2. Africa Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Artificial Intelligence (AI) In Drug Discovery Market Competitive Landscape And Company Profiles

  • 30.1. Artificial Intelligence (AI) In Drug Discovery Market Competitive Landscape
  • 30.2. Artificial Intelligence (AI) In Drug Discovery Market Company Profiles
    • 30.2.1. IBM Corporation
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Microsoft Corporation
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. NVIDIA Corporation
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Exscientia
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Alphabet
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Artificial Intelligence (AI) In Drug Discovery Market Other Major And Innovative Companies

  • 31.1. Atomwise Inc.
  • 31.2. Insilico Medicine
  • 31.3. Owkin Inc
  • 31.4. Xtalpi Inc
  • 31.5. Cloud Pharmaceuticals
  • 31.6. Shanghai Pharmaceutics
  • 31.7. Standigm
  • 31.8. Indegene
  • 31.9. Intuition Systems
  • 31.10. Innoplexus
  • 31.11. Takeda Pharmaceutical Company Ltd.
  • 31.12. RxPrism
  • 31.13. Otsuka Pharmaceutical Co. Ltd.
  • 31.14. China National Pharmaceutical Group Co., Ltd.
  • 31.15. Jiangsu Hengrui Medicine Co., Ltd

32. Global Artificial Intelligence (AI) In Drug Discovery Market Competitive Benchmarking

33. Global Artificial Intelligence (AI) In Drug Discovery Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Artificial Intelligence (AI) In Drug Discovery Market

35. Artificial Intelligence (AI) In Drug Discovery Market Future Outlook and Potential Analysis

  • 35.1 Artificial Intelligence (AI) In Drug Discovery Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Artificial Intelligence (AI) In Drug Discovery Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Artificial Intelligence (AI) In Drug Discovery Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer